Galmed Pharmaceuticals (GLMD) P/E (2014 - 2026)
Galmed Pharmaceuticals (GLMD) P/E from Dec 31, 2014 to Jul 21, 2026. The TTM Galmed Pharmaceuticals (GLMD) P/E is -0.33. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Galmed Pharmaceuticals (GLMD)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.33 | -30.85% |
| 2025 | -0.48 | -32.17% |
| 2024 | -0.71 | +100.97% |
| 2023 | -0.35 | -93.93% |
| 2022 | -5.79 | -72.53% |
| 2021 | -21.09 | -39.00% |
| 2020 | -34.57 | -61.40% |
| 2019 | -89.54 | -58.98% |
| 2018 | -218.31 | +122.00% |
| 2017 | -98.34 | +78.76% |
| 2016 | -55.01 | -53.88% |
| 2015 | -119.27 | +12.43% |
| 2014 | -106.08 | N/A |
Comparison Galmed Pharmaceuticals (GLMD) P/E with competitors
Galmed Pharmaceuticals (GLMD) P/E is -0.33.